Response in Japanese link for cardiac tests:
This article was originally published in Clinica
International Reagents is to buy an exclusive option to evaluate Response Biomedical's RAMP point-of-care cardiac diagnostic system in Japan. The two companies envisage that Vancouver, British Columbia-based Response will develop and manufacture tests for the three main cardiac markers to diagnose heart attack. International Reagents, a subsidiary of Yoshitomi Pharmaceutical Industries based in Kobe, Japan, will fund the trials, registration, sales and marketing in Japan and will receive a share in the profits. Financial terms were not disclosed.